Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.

Affiliation

Department of Urology, Mayo Clinic, Rochester, MN. Electronic address: [Email]

Abstract

The objective of the study was to determine whether sarcopenia is associated with pathologic and survival outcomes for patients with muscle-invasive bladder cancer (MIBC) treated with neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC).

Keywords

Body composition,Neoadjuvant therapy,Radical cystectomy,Sarcopenia,

OUR Recent Articles